The Rise of Companion Diagnostics
Companion Diagnostics can identify patients who are most likely to benefit from a particular therapeutic, highlight those at increased risk for serious side effects as a result of treatment with a particular therapeutic, and monitor treatment response to a particular therapeutic.
Since the approval of Herceptin® in 1998, companion diagnostics have played a vital role in the safe and effective use of a corresponding drug.
Learn more about companion diagnostics including:
- the growth in the market
- the technologies used
- the challenges and benefits
- the future